Evidence map›Paper›PMID 39911935›Full record

ArticleJournal of clinical and translational science2025

Duke Research at Pickett: The evolution of a free-standing research site partnering with communities toward health equity advancement.

Laura Van Althuis, Sally Taylor, Debra Freeman, Stephanie Freel, Lynn Sutton, Kenisha Bethea, Leatrice Martin, Amanda McMillan, Diane Williams Garber, Keisha Bentley-Edwards and 3 more

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Laura Van AlthuisDuke University School of Medicine, Duke Office of Clinical Research, Durham, NC, USA.ORCID https://orcid.org/0000-0002-0086-6504
Sally TaylorDuke University School of Medicine, Duke Office of Clinical Research, Durham, NC, USA.ORCID https://orcid.org/0009-0004-3379-7746
Debra FreemanDuke University School of Medicine, Duke Office of Clinical Research, Durham, NC, USA.
Stephanie FreelDuke University School of Medicine, Duke Office of Clinical Research, Durham, NC, USA.ORCID https://orcid.org/0000-0002-8525-3271
Lynn SuttonDuke University School of Medicine, Duke Clinical & Translational Science Institute, Durham, NC, USA.ORCID https://orcid.org/0009-0008-7913-1041
Kenisha BetheaDuke University School of Medicine, Duke Clinical & Translational Science Institute, Durham, NC, USA.
Leatrice MartinDuke University School of Medicine, Duke Clinical & Translational Science Institute, Durham, NC, USA.ORCID https://orcid.org/0000-0001-9979-1516
Amanda McMillanDuke University School of Medicine, Duke Clinical & Translational Science Institute, Durham, NC, USA.
Diane Williams GarberDuke University School of Medicine, Duke Office of Clinical Research, Durham, NC, USA.
Keisha Bentley-EdwardsDuke University School of Medicine, Duke Clinical & Translational Science Institute, Durham, NC, USA.ORCID https://orcid.org/0000-0001-8430-4850
Nadine BarrettWake Forest University School of Medicine, Social Science and Health Policy, Division of Public Health Sciences, Winston-Salem, NC, USA.ORCID https://orcid.org/0000-0003-0439-5209
Denise C SnyderDuke University School of Medicine, Duke Office of Clinical Research, Durham, NC, USA.ORCID https://orcid.org/0000-0003-1160-7433
Susanna NaggieDuke University School of Medicine, Duke Clinical & Translational Science Institute, Durham, NC, USA.ORCID https://orcid.org/0000-0001-7721-6975

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While clinical research intends to improve health outcomes for all, access to research participation is often limited and inequitable. Geographic proximity is a recognized barrier, thus, systemic infrastructure solutions through federal programs including General Clinical Research Centers and Clinical and Translational Science Awards have sought to improve accessibility. Even with such support, academic medical centers often have limited clinical research-dedicated space apart from shared exam rooms in difficult-to-navigate hospitals or clinics. In 2019, the Duke University School of Medicine looked beyond its medical center campus to identify free-standing sites within Durham communities for participant study visits. Catalyzed by the COVID-19 pandemic, Duke Research at Pickett, a 22 000-square-foot building with a laboratory, 30 exam rooms, and on-site parking, opened in October 2020 to support vaccine and treatment trials. Upon the lifting of many COVID-19 restrictions, and in partnership with the Research Equity and Diversity Initiative (READI) Community Advisory Council, the building was transformed to encourage community gatherings, education, and training programs. To date, Duke Research at Pickett has hosted 2692 participants in 78 research trials and 14 community-engaged activities.

Indexed as

community engagementCTSAdiversityeducationresearch infrastructureresearch training

Identifiers

PMID39911935
PMCPMC11795852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.